Statistics for Zivo Bioscience, (id:5960 ZIVO)
Valuation metrics
Market cap
75.83M
Enterprise value
75.90M
Trailing P/E (ttm)
-4.57
Forward P/E
-17.88
PEG ratio
-17.88
Price/Sales (ttm)
2.74K
Price/Book (mrq)
-27.09
Enterprise Value/Revenue
2.75K
Enterprise Value/EBITDA
-10.45
Overview
Shares outstanding
3.54M
Float
1.30M
Shares short
35.46K
% Held by insiders
0.47%
% Held by institutions
0.00%
Average volume (10 days)
1.33K
Average volume (90 days)
Price summary
52-Week low
0.48
52-Week high
22.15
52-Week change
94.76%
Beta
0.26
50-Day moving average
18.06
200-Day moving average
10.72
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 27th, 2023
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
41.99%
Operating margin
-26,267.67%
Operational effectiveness
Return on assets
-1,399.49%
Return on equity
352.57%
Income statement
Revenue (ttm)
0.02
Revenue per share (ttm)
0.02
Quarterly revenue growth (yoy)
Gross profit (ttm)
11.61K
EBITDA
0.00
Net income to common (ttm)
-7,777,184.00
Diluted EPS (ttm)
-5.33
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.47K
Total cash per share (mrq)
0.00
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
17.24%
Book value per share (mrq)
-0.93
Cash flow
Cash flow statement
-6,508,041.00
Levered free cash flow (LFCF)
-7,777,184.00